Literature DB >> 15204144

Oral lichen planus: an overview.

Joachim Dissemond1.   

Abstract

Lichen planus (LP) is a chronic inflammatory muco-cutaneous disease. Since disorders of NK-cell functional activity could be observed in patients with LP, it is considered to be an autoimmune disease. The pathogenesis of LP is complex and not completely understood. The involvement of mucous membranes is frequently seen, usually asymptomatic, but occasionally complicated by extensive painful erosions, causing a considerable loss of quality of life. Patients with symptomatic oral lichen planus (OLP) often require intensive therapy to reduce the signs and symptoms of this painful and disabling inflammatory disease. OLP is considered to be a precancerous lesion for the development of squamous cell carcinomas. OLP is highly resistant to topical treatment and tends to pursue a chronic course with little tendency to spontaneous resolution. Until now meta-analysis provided little evidence for the superiority of the assessed interventions over placebo for palliation of symptomatic OLP.

Entities:  

Mesh:

Year:  2004        PMID: 15204144     DOI: 10.1080/09546630410030720

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  17 in total

1.  [Involvement of mucous membranes in papulosquamous diseases].

Authors:  M Sticherling
Journal:  Hautarzt       Date:  2009-11       Impact factor: 0.751

Review 2.  Photodynamic therapy in dentistry: a literature review.

Authors:  Hare Gursoy; Ceyda Ozcakir-Tomruk; Jale Tanalp; Selçuk Yilmaz
Journal:  Clin Oral Investig       Date:  2012-09-27       Impact factor: 3.573

3.  Serum autoantibodies to desmogleins 1 and 3 in patients with oral lichen planus.

Authors:  Josip Lukac; Suzana Brozović; Vanja Vucicević-Boras; Marinka Mravak-Stipetić; Branko Malenica; Zvonko Kusić
Journal:  Croat Med J       Date:  2006-02       Impact factor: 1.351

4.  Efficacy of platelet-rich fibrin compared with triamcinolone acetonide as injective therapy in the treatment of symptomatic oral lichen planus: a pilot study.

Authors:  Francesco Bennardo; Francesco Liborio; Selene Barone; Alessandro Antonelli; Caterina Buffone; Leonzio Fortunato; Amerigo Giudice
Journal:  Clin Oral Investig       Date:  2021-01-07       Impact factor: 3.573

5.  Role of human papilloma virus-16 in the pathogenesis of oral lichen planus--an immunohistochemical study.

Authors:  Chetan A Pol; Suvarna K Ghige; Suchitra R Gosavi
Journal:  Int Dent J       Date:  2014-09-25       Impact factor: 2.607

6.  Expression of human DNA mismatch-repair protein, hMSH2, in patients with oral lichen planus.

Authors:  Hao-Bo Li; Ying-Huai Zhang; Hui-Zhen Chen; Yong Chen
Journal:  Exp Ther Med       Date:  2014-11-06       Impact factor: 2.447

7.  A retrospective study of 171 patients with oral lichen planus in the East Bohemia - Czech Republic - single center experience.

Authors:  Vladimíra Radochová; Ivo Dřízhal; Radovan Slezák
Journal:  J Clin Exp Dent       Date:  2014-12-01

8.  A Comparative Evaluation of Low-Level Laser and Topical Steroid Therapies for the Treatment of Erosive-Atrophic Lichen Planus.

Authors:  Hanaa M El Shenawy; Amany Mohy Eldin
Journal:  Open Access Maced J Med Sci       Date:  2015-08-07

9.  A retrospective study of 370 patients with oral lichen planus in Turkey.

Authors:  Birsay Gümrü
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-05-01

10.  Expression of novel p53 isoforms in oral lichen planus.

Authors:  Majid Ebrahimi; Linda Boldrup; Philip J Coates; Ylva-Britt Wahlin; Jean-Christophe Bourdon; Karin Nylander
Journal:  Oral Oncol       Date:  2007-04-05       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.